Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated and detail-oriented individual to support and advance mass spectrometry-based proteomics workflows. This role is well-suited for a scientist with prior industry experience who is excited to apply and expand their expertise in proteomics within a drug discovery environment. This position will involve executing and optimizing laboratory workflows, maintaining high-quality data standards, and contributing to the development of new capabilities within the team. The ideal candidate will demonstrate strong technical proficiency, attention to detail, and the ability to work both independently and collaboratively. In this role, success will come from consistently delivering high-quality, reproducible data, maintaining well-documented experiments, and proactively identifying opportunities to improve workflows and efficiency.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior